Glaukos Corporation

Aliso Viejo, California, United States glaukos.com

Overview

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on developing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) and offers a range of innovative products, including the iStent platform and the iDose TR implant.

Therapeutic areas

GlaucomaCorneal DisordersRetinal Diseases

FDA compliance signals

1 FDA enforcement record linked to this company.

  • 4832025-04-22

    Investigations of discrepancies, failures

Related companies

Insite Vision Incorporated
United States
Perceive Biotherapeutics, Inc.
United States
Laboratoires Théa S.A.S.
France
Nicox Ophthalmics, Inc.
France
Nicox S.A.
France
Opthea Limited
Australia
Santen Pharmaceutical Co., Ltd.
Japan
10x Genomics, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo